The present study showed that the following factors were involved in the efficiency of the causal effects due to directly administered reprogramming factors in the liver in vivo: i) immunodeficiency; ii) extracellular components such as uPA; and iii) activation of oncogenic Kras in mesenchymal cells. The gene discussed is KRAS; the disease is Immunodeficiency.